TITANIUM DIOXIDE

TITANIUM DIOXIDE was reported 243 times

TITANIUM DIOXIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HYPOFERRITINAEMIA 1 0.0500
1 GASTROINTESTINAL MELANOSIS 1 0.0182
2 PINGUECULA 1 0.0094
3 EXPOSURE TO MOULD 1 0.0079
4 BACTEROIDES INFECTION 2 0.0077
5 APPLICATION SITE NODULE 1 0.0073
6 PRESBYACUSIS 2 0.0065
7 SOCIOECONOMIC PRECARITY 1 0.0058
8 REACTION TO EXCIPIENT 13 0.0056
9 APPENDICOLITH 2 0.0052
10 HEAVY EXPOSURE TO ULTRAVIOLET LIGHT 1 0.0047
11 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 1 0.0043
12 XEROSIS 5 0.0040
13 LENTIGO 2 0.0040
14 SOLAR DERMATITIS 1 0.0037
15 CHEMICAL BURNS OF EYE 1 0.0036
16 ALLERGY TO METALS 2 0.0033
17 TOOTH REPAIR 1 0.0028
18 ALLERGY TO CHEMICALS 3 0.0024
19 PYOGENIC GRANULOMA 1 0.0021
20 VAGINAL DISORDER 2 0.0021
21 HYPERCREATININAEMIA 1 0.0020
22 HYPEREOSINOPHILIC SYNDROME 1 0.0018
23 APPLICATION SITE DISCHARGE 2 0.0017
24 ALLERGIC REACTION TO EXCIPIENT 3 0.0015
25 FUNGAL OESOPHAGITIS 1 0.0014
26 SEBORRHOEIC KERATOSIS 2 0.0014
27 LIP ERYTHEMA 1 0.0013
28 GUTTATE PSORIASIS 1 0.0012
29 SUNBURN 9 0.0012
30 MILIARIA 2 0.0012
31 MADAROSIS 13 0.0011
32 INJECTION SITE DRYNESS 1 0.0011
33 C-REACTIVE PROTEIN 1 0.0011
34 FACIAL ASYMMETRY 1 0.0010
35 CROSS SENSITIVITY REACTION 1 0.0010
36 IMMUNE-MEDIATED HEPATITIS 2 0.0010
37 HYPERPHOSPHATAEMIA 2 0.0009
38 REACTION TO DRUG EXCIPIENTS 2 0.0009
39 CHEMICAL BURN 1 0.0009
40 MALIGNANT MELANOMA IN SITU 1 0.0008
41 JOINT WARMTH 1 0.0008
42 ACTINIC KERATOSIS 2 0.0008
43 GLYCOSURIA 1 0.0007
44 SKIN DEPIGMENTATION 1 0.0007
45 BLOOD PHOSPHORUS INCREASED 2 0.0007
46 MENINGITIS VIRAL 1 0.0007
47 CENTRAL NERVOUS SYSTEM LYMPHOMA 1 0.0007
48 VASCULAR INJURY 1 0.0007
49 SENSITIVE SKIN 5 0.0007
50 CONJUNCTIVITIS ALLERGIC 1 0.0007
51 ACNE CYSTIC 2 0.0007
52 SUSPECTED COVID-19 2 0.0006
53 SEBORRHOEIC DERMATITIS 1 0.0006
54 ARTHROPOD STING 1 0.0006
55 MALIGNANT MELANOMA 8 0.0006
56 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
57 CHEILITIS 3 0.0006
58 NASAL OEDEMA 1 0.0006
59 PANCREATIC CYST 1 0.0005
60 APLASIA 1 0.0005
61 UNDERWEIGHT 1 0.0005
62 APPLICATION SITE DISCOLOURATION 2 0.0005
63 DERMATITIS PSORIASIFORM 1 0.0005
64 PIGMENTATION DISORDER 3 0.0005
65 APPLICATION SITE EXFOLIATION 2 0.0005
66 WALKING DISABILITY 1 0.0005
67 LIP OEDEMA 2 0.0005
68 FEBRILE BONE MARROW APLASIA 2 0.0005
69 APPLICATION SITE SCAB 1 0.0005
70 DIVERTICULUM INTESTINAL 2 0.0005
71 MELANOCYTIC NAEVUS 2 0.0005
72 PRODUCT LOT NUMBER ISSUE 1 0.0005
73 IRON DEFICIENCY 2 0.0004
74 METASTATIC MALIGNANT MELANOMA 1 0.0004
75 HAEMANGIOMA 1 0.0004
76 LOCALISED OEDEMA 2 0.0004
77 VITILIGO 1 0.0004
78 PHOTOSENSITIVITY REACTION 7 0.0004
79 EYE OEDEMA 1 0.0004
80 VENTRICULAR DYSFUNCTION 1 0.0004
81 BASAL CELL CARCINOMA 6 0.0004
82 ANAL FISTULA 2 0.0004
83 SKIN DISCOMFORT 1 0.0004
84 APPLICATION SITE HAEMORRHAGE 1 0.0004
85 RED BLOOD CELL COUNT INCREASED 1 0.0004
86 VITREOUS HAEMORRHAGE 1 0.0004
87 RASH MORBILLIFORM 1 0.0004
88 CHOLECYSTITIS ACUTE 2 0.0004
89 SKIN HYPERPIGMENTATION 3 0.0003
90 BLOOD URIC ACID INCREASED 2 0.0003
91 SKIN WARM 2 0.0003
92 RESTLESS LEGS SYNDROME 6 0.0003
93 POLYP 2 0.0003
94 BRONCHIECTASIS 2 0.0003
95 TONGUE ULCERATION 1 0.0003
96 ABNORMAL LOSS OF WEIGHT 2 0.0003
97 AORTIC STENOSIS 1 0.0003
98 DERMATITIS 6 0.0003
99 SCLERODERMA 1 0.0003
100 INTENTIONAL UNDERDOSE 2 0.0003
101 UTERINE LEIOMYOMA 2 0.0003
102 BLOOD PHOSPHORUS DECREASED 1 0.0003
103 HYPOPHOSPHATAEMIA 2 0.0003
104 TROPONIN INCREASED 2 0.0003
105 OESOPHAGEAL ULCER 1 0.0003
106 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
107 MIOSIS 2 0.0002
108 MYASTHENIA GRAVIS 2 0.0002
109 TRIGGER FINGER 1 0.0002
110 SELF-INJURIOUS IDEATION 1 0.0002
111 OCULAR ICTERUS 1 0.0002
112 APPLICATION SITE ERYTHEMA 6 0.0002
113 GINGIVAL SWELLING 1 0.0002
114 BACTERIAL INFECTION 4 0.0002
115 APPENDICITIS 2 0.0002
116 SKIN TIGHTNESS 1 0.0002
117 SQUAMOUS CELL CARCINOMA 2 0.0002
118 ENDOMETRIOSIS 1 0.0002
119 RASH ERYTHEMATOUS 10 0.0002
120 INCORRECT DOSAGE ADMINISTERED 1 0.0002
121 ORGANISING PNEUMONIA 1 0.0002
122 APPLICATION SITE SWELLING 1 0.0002
123 AMMONIA INCREASED 1 0.0002
124 TONSILLITIS 1 0.0002
125 SKIN CANCER 4 0.0002
126 ANAL ABSCESS 1 0.0002
127 APPLICATION SITE PAIN 4 0.0002
128 CHOKING SENSATION 1 0.0002
129 HYPERKERATOSIS 1 0.0002
130 ANGIOPATHY 1 0.0002
131 ACUTE PULMONARY OEDEMA 1 0.0002
132 DERMATITIS CONTACT 2 0.0002
133 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
134 SKIN ATROPHY 1 0.0002
135 RALES 1 0.0002
136 RASH MACULAR 6 0.0002
137 ACNE 13 0.0002
138 HYPERTRIGLYCERIDAEMIA 1 0.0002
139 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
140 CATARACT OPERATION 1 0.0002
141 HYPERLIPIDAEMIA 2 0.0002
142 BURSITIS 2 0.0002
143 NEURALGIA 4 0.0002
144 PRE-EXISTING CONDITION IMPROVED 1 0.0002
145 ROTATOR CUFF SYNDROME 2 0.0002
146 APPLICATION SITE VESICLES 1 0.0002
147 SWELLING FACE 10 0.0002
148 IMMUNE SYSTEM DISORDER 2 0.0002
149 SKIN MASS 1 0.0001
150 PAIN OF SKIN 4 0.0001
151 DROOLING 1 0.0001
152 ENCEPHALITIS 1 0.0001
153 RETINAL HAEMORRHAGE 1 0.0001
154 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
155 CARDIOGENIC SHOCK 2 0.0001
156 HYPERTHYROIDISM 2 0.0001
157 RASH PUSTULAR 1 0.0001
158 ASCITES 4 0.0001
159 SKIN HAEMORRHAGE 2 0.0001
160 RASH MACULO-PAPULAR 3 0.0001
161 RASH PAPULAR 3 0.0001
162 ACIDOSIS 1 0.0001
163 BOWEL MOVEMENT IRREGULARITY 1 0.0001
164 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
165 TENDONITIS 2 0.0001
166 PULMONARY HAEMORRHAGE 1 0.0001
167 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
168 BLOOD ALBUMIN DECREASED 1 0.0001
169 ULCER 2 0.0001
170 HYPERSENSITIVITY 23 0.0001
171 MUSCLE DISORDER 1 0.0001
172 HYPERAESTHESIA 1 0.0001
173 SKIN PLAQUE 1 0.0001
174 CANDIDA INFECTION 2 0.0001
175 PRODUCT COMPLAINT 3 0.0001
176 CARDIAC MURMUR 1 0.0001
177 NAIL DISORDER 1 0.0001
178 BLOOD CALCIUM INCREASED 1 0.0001
179 IMMUNOSUPPRESSION 1 0.0001
180 GOUT 2 0.0001
181 OSTEOMYELITIS 2 0.0001
182 LIP DRY 1 0.0001
183 MOOD ALTERED 3 0.0001
184 SKIN LESION 3 0.0001
185 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
186 SPINAL DISORDER 1 0.0001
187 SPUTUM DISCOLOURED 1 0.0001
188 BLOOD URINE PRESENT 2 0.0001
189 CHOLESTASIS 2 0.0001
190 TOXIC SKIN ERUPTION 1 0.0001
191 PETECHIAE 1 0.0001
192 FOLLICULITIS 1 0.0001
193 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
194 SCRATCH 1 0.0001
195 BODY HEIGHT DECREASED 1 0.0001
196 OESOPHAGITIS 1 0.0001
197 ASPIRATION 1 0.0001
198 VENTRICULAR FIBRILLATION 1 0.0001
199 NERVE INJURY 1 0.0001
200 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
201 BLISTER 5 0.0001
202 SCAB 1 0.0001
203 SKIN IRRITATION 4 0.0001
204 DRY MOUTH 7 0.0001
205 VASCULITIS 1 0.0001
206 THYROID CANCER 1 0.0001
207 ABDOMINAL PAIN UPPER 17 0.0001
208 CARDIOMEGALY 1 0.0001
209 PHARYNGITIS 1 0.0001
210 APPLICATION SITE IRRITATION 1 0.0001
211 HAIR COLOUR CHANGES 1 0.0001
212 DRY EYE 4 0.0001
213 INTENTIONAL PRODUCT MISUSE 7 0.0001
214 ERYTHEMA 16 0.0001
215 NODULE 1 0.0001
216 ECZEMA 4 0.0001
217 INCORRECT PRODUCT STORAGE 1 0.0001
218 FREQUENT BOWEL MOVEMENTS 2 0.0001
219 TACHYPNOEA 1 0.0001
220 LUNG NEOPLASM MALIGNANT 3 0.0001
221 PERIPHERAL COLDNESS 1 0.0001
222 APPLICATION SITE RASH 1 0.0001
223 DIVERTICULITIS 2 0.0001
224 SKIN REACTION 1 0.0001
225 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
226 BRONCHOSPASM 1 0.0001
227 IMPAIRED QUALITY OF LIFE 1 0.0001
228 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
229 IMMUNODEFICIENCY 1 0.0001
230 HYPOAESTHESIA ORAL 1 0.0001
231 TINNITUS 3 0.0001
232 SKIN DISCOLOURATION 3 0.0001
233 PHARYNGEAL OEDEMA 1 0.0001
234 BLOOD CHOLESTEROL INCREASED 3 0.0001
235 DRUG INTOLERANCE 6 0.0001
236 BACK DISORDER 1 0.0001
237 LUNG DISORDER 3 0.0001
238 DRY SKIN 8 0.0001
239 TYPE 2 DIABETES MELLITUS 2 0.0001
240 FACE OEDEMA 1 0.0001
241 SKIN EXFOLIATION 5 0.0001
242 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
243 SCAR 1 0.0001
244 MUSCULOSKELETAL DISCOMFORT 1 0.0001
245 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
246 ABDOMINAL DISTENSION 6 0.0001
247 SLEEP DISORDER 4 0.0001
248 LYMPHOCYTE COUNT DECREASED 1 0.0001
249 THIRST 1 0.0001
250 SKIN BURNING SENSATION 4 0.0001
251 GASTROENTERITIS VIRAL 1 0.0001
252 END STAGE RENAL DISEASE 1 0.0001
253 PSORIASIS 7 0.0001
254 SWELLING 5 0.0001
255 GASTRIC ULCER 1 0.0001
256 PROTEINURIA 1 0.0001
257 DIABETES MELLITUS 4 0.0001
258 DISABILITY 1 0.0001
259 CYTOKINE RELEASE SYNDROME 1 0.0000
260 PSORIATIC ARTHROPATHY 2 0.0000
261 BONE MARROW FAILURE 1 0.0000
262 INJURY ASSOCIATED WITH DEVICE 1 0.0000
263 POLLAKIURIA 2 0.0000
264 MOUTH ULCERATION 1 0.0000
265 LIVER FUNCTION TEST INCREASED 1 0.0000
266 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
267 NEOPLASM MALIGNANT 3 0.0000
268 GLOSSODYNIA 1 0.0000
269 APPLICATION SITE PRURITUS 1 0.0000
270 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
271 BURNING SENSATION 3 0.0000
272 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
273 DYSPHAGIA 4 0.0000
274 PULMONARY EMBOLISM 4 0.0000
275 UNDERDOSE 3 0.0000
276 SYNCOPE 4 0.0000
277 HYPOPHAGIA 1 0.0000
278 HEPATITIS 1 0.0000
279 RASH 17 0.0000
280 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
281 INFLAMMATION 2 0.0000
282 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
283 THROMBOSIS 3 0.0000
284 JAUNDICE 1 0.0000
285 OEDEMA 2 0.0000
286 ANAPHYLACTIC REACTION 2 0.0000
287 URTICARIA 6 0.0000
288 WOUND 1 0.0000
289 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
290 EYE PAIN 2 0.0000
291 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
292 INTENTIONAL DOSE OMISSION 1 0.0000
293 HYPERSOMNIA 1 0.0000
294 SOMNOLENCE 7 0.0000
295 EYE IRRITATION 2 0.0000
296 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
297 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
298 PSYCHOTIC DISORDER 1 0.0000
299 TACHYCARDIA 3 0.0000
300 URINARY INCONTINENCE 1 0.0000
301 RESPIRATORY DISORDER 1 0.0000
302 LACRIMATION INCREASED 1 0.0000
303 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
304 ADVERSE EVENT 3 0.0000
305 CHEST PAIN 6 0.0000
306 VISUAL IMPAIRMENT 4 0.0000
307 NERVOUS SYSTEM DISORDER 1 0.0000
308 PRODUCT USE ISSUE 6 0.0000
309 MIGRAINE 3 0.0000
310 HYPOTHYROIDISM 1 0.0000
311 PAIN IN EXTREMITY 9 0.0000
312 HEART RATE INCREASED 3 0.0000
313 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
314 EXPIRED PRODUCT ADMINISTERED 1 0.0000
315 SKIN DISORDER 1 0.0000
316 URINARY RETENTION 1 0.0000
317 CONDITION AGGRAVATED 9 0.0000
318 HAEMATURIA 1 0.0000
319 ILLNESS 3 0.0000
320 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
321 MOBILITY DECREASED 2 0.0000
322 MYELOSUPPRESSION 1 0.0000
323 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
324 DRUG EFFECT INCOMPLETE 1 0.0000
325 HYPERGLYCAEMIA 1 0.0000
326 INJECTION SITE MASS 1 0.0000
327 DYSPNOEA EXERTIONAL 1 0.0000
328 COLITIS 1 0.0000
329 DEPRESSION 6 0.0000
330 BLOOD PRESSURE INCREASED 4 0.0000
331 PLASMA CELL MYELOMA 1 0.0000
332 JOINT SWELLING 3 0.0000
333 NEUTROPHIL COUNT DECREASED 1 0.0000
334 INFLUENZA LIKE ILLNESS 2 0.0000
335 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
336 HYPERTENSION 5 0.0000
337 HYPERHIDROSIS 3 0.0000
338 RECTAL HAEMORRHAGE 1 0.0000
339 SEPTIC SHOCK 1 0.0000
340 PRODUCT STORAGE ERROR 2 0.0000
341 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
342 ANGIOEDEMA 1 0.0000
343 NEPHROLITHIASIS 1 0.0000
344 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
345 DECREASED APPETITE 5 0.0000
346 RENAL DISORDER 1 0.0000
347 OCULAR HYPERAEMIA 1 0.0000
348 DISEASE RECURRENCE 1 0.0000
349 ANAEMIA 4 0.0000
350 PRODUCTIVE COUGH 1 0.0000
351 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
352 PRURITUS 8 0.0000
353 CONTUSION 2 0.0000
354 DYSPEPSIA 2 0.0000
355 LEUKOPENIA 1 0.0000
356 HOSPITALISATION 3 0.0000
357 MUSCULOSKELETAL PAIN 1 0.0000
358 DERMATITIS ATOPIC 1 0.0000
359 CONFUSIONAL STATE 3 0.0000
360 DISTURBANCE IN ATTENTION 1 0.0000
361 RASH PRURITIC 1 0.0000
362 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
363 HAEMATOCHEZIA 1 0.0000
364 SEPSIS 2 0.0000
365 PANCYTOPENIA 1 0.0000
366 ABDOMINAL DISCOMFORT 3 0.0000
367 OXYGEN SATURATION DECREASED 1 0.0000
368 HYPONATRAEMIA 1 0.0000
369 DYSPNOEA 10 0.0000
370 FLATULENCE 1 0.0000
371 CONVULSION 1 0.0000
372 HERPES ZOSTER 1 0.0000
373 SEIZURE 2 0.0000
374 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
375 ABDOMINAL PAIN 4 0.0000
376 PALPITATIONS 2 0.0000
377 NASAL CONGESTION 1 0.0000
378 IRRITABILITY 1 0.0000
379 STOMATITIS 1 0.0000
380 OEDEMA PERIPHERAL 2 0.0000
381 VERTIGO 1 0.0000
382 DISCOMFORT 1 0.0000
383 MUSCLE SPASMS 3 0.0000
384 FEELING HOT 1 0.0000
385 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
386 PAIN 10 0.0000
387 HEADACHE 10 0.0000
388 PRODUCT DOSE OMISSION 1 0.0000
389 FEBRILE NEUTROPENIA 1 0.0000
390 BLOOD PRESSURE DECREASED 1 0.0000
391 DEHYDRATION 2 0.0000
392 INJECTION SITE PRURITUS 1 0.0000
393 PRODUCT QUALITY ISSUE 2 0.0000
394 INJECTION SITE REACTION 1 0.0000
395 WEIGHT DECREASED 4 0.0000
396 COUGH 4 0.0000
397 ANXIETY 4 0.0000
398 INFECTION 2 0.0000
399 CONSTIPATION 3 0.0000
400 RESPIRATORY FAILURE 1 0.0000
401 MALAISE 6 0.0000
402 EPISTAXIS 1 0.0000
403 HOT FLUSH 1 0.0000
404 INJECTION SITE SWELLING 1 0.0000
405 PERIPHERAL SWELLING 2 0.0000
406 OFF LABEL USE 11 0.0000
407 INJECTION SITE HAEMORRHAGE 1 0.0000
408 CARDIAC FAILURE CONGESTIVE 1 0.0000
409 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
410 ARTHRALGIA 5 0.0000
411 CEREBROVASCULAR ACCIDENT 2 0.0000
412 MYALGIA 2 0.0000
413 BALANCE DISORDER 1 0.0000
414 FATIGUE 9 0.0000
415 MUSCULOSKELETAL STIFFNESS 1 0.0000
416 COVID-19 2 0.0000
417 NAUSEA 9 0.0000
418 INSOMNIA 3 0.0000
419 GASTROINTESTINAL DISORDER 1 0.0000
420 SUICIDAL IDEATION 1 0.0000
421 DIARRHOEA 7 0.0000
422 OROPHARYNGEAL PAIN 1 0.0000
423 ASTHENIA 4 0.0000
424 BLOOD GLUCOSE INCREASED 2 0.0000
425 ATRIAL FIBRILLATION 1 0.0000
426 ALOPECIA 2 0.0000
427 FLUSHING 1 0.0000
428 HAEMOGLOBIN DECREASED 1 0.0000
429 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
430 HAEMORRHAGE 1 0.0000
431 DEATH 8 0.0000
432 OVERDOSE 2 0.0000
433 PNEUMONIA 3 0.0000
434 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
435 THROMBOCYTOPENIA 1 0.0000
436 ASTHMA 1 0.0000
437 MUSCULAR WEAKNESS 1 0.0000
438 PYREXIA 3 0.0000
439 BACK PAIN 2 0.0000
440 DISEASE PROGRESSION 1 0.0000
441 FEELING ABNORMAL 2 0.0000
442 EMOTIONAL DISTRESS 1 0.0000
443 NEUTROPENIA 1 0.0000
444 VISION BLURRED 1 0.0000
445 PRODUCT DOSE OMISSION ISSUE 2 0.0000
446 HYPOAESTHESIA 1 0.0000
447 ACUTE KIDNEY INJURY 1 0.0000
448 INJECTION SITE PAIN 2 0.0000
449 VOMITING 3 0.0000
450 PARAESTHESIA 1 0.0000
451 FALL 2 0.0000
452 NASOPHARYNGITIS 1 0.0000
453 DRUG INEFFECTIVE 7 0.0000
454 GAIT DISTURBANCE 1 0.0000
455 HYPOTENSION 1 0.0000
456 WEIGHT INCREASED 1 0.0000
457 INCORRECT DOSE ADMINISTERED 1 0.0000